How APOL1 Mutations Impact Mitochondrial Function in Kidney Disease Revealed by Organoid Models
New research using kidney organoids uncovers how APOL1 gene mutations impair mitochondrial function, shedding light on mechanisms behind genetic kidney disease and opening doors for targeted therapies.
Recent groundbreaking research utilizing kidney organoids has shed light on the role of genetic mutations in the development of chronic kidney disease (CKD). CKD affects over 700 million individuals worldwide and is influenced by a combination of genetic, environmental, and medical factors. Notably, mutations in the APOL1 gene are significant genetic risk factors, especially prevalent among individuals of West African descent, where up to 13% carry risk variants and 38% are carriers.
To better understand how these mutations contribute to kidney disease, researchers from the University of Leiden in the Netherlands, led by Siebe Spijker, generated stem cells from skin biopsies of patients with APOL1-associated kidney disease. These stem cells were then differentiated into kidney organoids—miniature, lab-grown structures that mimic many aspects of actual kidney tissue. By employing genetic engineering techniques, the team corrected APOL1 mutations within some organoids to compare their functions.
The study, published in Stem Cell Reports, employed various laboratory tests demonstrating that APOL1 mutations disrupt mitochondrial function—the cell’s energy-producing structures—in kidney cells. Specifically, podocytes, key cells in the kidney’s filtration system, showed heightened vulnerability, especially under stress conditions involving inflammatory proteins. This insight suggests that inflammation, often resulting from viral infections or autoimmune diseases, may trigger or exacerbate APOL1-related kidney problems.
Spijker and his team highlighted that the human kidney organoid model could accelerate drug discovery for APOL1-associated kidney disease, a condition difficult to study in animals since APOL1 is not naturally expressed in rodents. The findings suggest that mutant APOL1 proteins impair mitochondrial respiration in podocytes, leading to cellular dysfunction and contributing to disease progression.
This research points toward potential therapeutic strategies targeting mitochondrial health and emphasizes the importance of inflammation control in managing APOL1-related kidney conditions. Overall, these insights provide a promising avenue for developing targeted treatments aimed at mitigating kidney damage caused by genetic mutations.
Source: https://medicalxpress.com/news/2025-10-kidney-organoids-reveal-apol1-mutations.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Let-7 Gene Acts as a Guardian of Lung Health, Preventing Pulmonary Fibrosis
A recent study uncovers the vital role of the let-7 gene in protecting the lungs from fibrosis, offering new insights into potential therapies for lung scarring diseases.
Enhanced Skin-to-Skin Contact with Newborns Driving Positive Outcomes Post-Training
Targeted training for healthcare professionals and parents significantly increases skin-to-skin contact with newborns, supporting better bonding and health outcomes in the first days of life.
Global Urgency to Combat the Rising Threat of Liver Diseases
A global movement highlights the urgent need for early detection and innovative care strategies to combat the rising tide of liver diseases like MASLD and MASH, aiming for a preventive approach ahead of 2030.
Uncovering the Hidden History of Fundraising for Hospital Imaging Technology
A groundbreaking report uncovers the vital role of fundraising in bringing advanced medical imaging technology to UK hospitals, highlighting decades of community efforts that have shaped modern healthcare.